A detailed history of Baillie Gifford & CO transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 121,855 shares of HCAT stock, worth $990,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121,855
Previous 430,597 71.7%
Holding current value
$990,681
Previous $2.75 Million 63.98%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$5.48 - $8.83 $1.69 Million - $2.73 Million
-308,742 Reduced 71.7%
121,855 $991,000
Q2 2024

Jul 25, 2024

SELL
$5.53 - $7.28 $587,125 - $772,924
-106,171 Reduced 19.78%
430,597 $2.75 Million
Q1 2024

May 01, 2024

SELL
$7.44 - $11.21 $11,532 - $17,375
-1,550 Reduced 0.29%
536,768 $4.04 Million
Q4 2023

Jan 26, 2024

SELL
$6.71 - $10.16 $193,368 - $292,790
-28,818 Reduced 5.08%
538,318 $4.98 Million
Q3 2023

Nov 13, 2023

SELL
$9.35 - $14.32 $218,023 - $333,913
-23,318 Reduced 3.95%
567,136 $5.74 Million
Q2 2023

Jul 28, 2023

SELL
$9.86 - $13.12 $111,506 - $148,374
-11,309 Reduced 1.88%
590,454 $7.38 Million
Q1 2023

May 03, 2023

BUY
$10.23 - $14.76 $29,165 - $42,080
2,851 Added 0.48%
601,763 $7.02 Million
Q4 2022

Jan 24, 2023

BUY
$6.86 - $11.32 $1.32 Million - $2.18 Million
192,959 Added 47.53%
598,912 $6.37 Million
Q3 2022

Oct 27, 2022

BUY
$9.3 - $18.27 $124,954 - $245,475
13,436 Added 3.42%
405,953 $3.94 Million
Q2 2022

Aug 08, 2022

SELL
$11.79 - $27.63 $561,793 - $1.32 Million
-47,650 Reduced 10.83%
392,517 $5.69 Million
Q1 2022

May 05, 2022

BUY
$20.67 - $40.33 $863,757 - $1.69 Million
41,788 Added 10.49%
440,167 $11.5 Million
Q4 2021

Jan 20, 2022

BUY
$36.68 - $54.02 $637,351 - $938,651
17,376 Added 4.56%
398,379 $15.8 Million
Q3 2021

Oct 19, 2021

BUY
$49.57 - $58.15 $4.04 Million - $4.74 Million
81,441 Added 27.19%
381,003 $19.1 Million
Q2 2021

Aug 02, 2021

BUY
$47.17 - $58.64 $1.73 Million - $2.15 Million
36,732 Added 13.98%
299,562 $16.6 Million
Q1 2021

May 06, 2021

BUY
$42.51 - $54.07 $5.98 Million - $7.61 Million
140,777 Added 115.34%
262,830 $12.3 Million
Q4 2020

Feb 10, 2021

BUY
$31.9 - $44.89 $1.91 Million - $2.68 Million
59,738 Added 95.86%
122,053 $5.31 Million
Q3 2020

Nov 12, 2020

BUY
$28.55 - $36.91 $1.61 Million - $2.08 Million
56,328 Added 940.84%
62,315 $2.28 Million
Q2 2020

Aug 12, 2020

BUY
$24.0 - $32.87 $63,240 - $86,612
2,635 Added 78.61%
5,987 $175,000
Q1 2020

May 08, 2020

BUY
$17.8 - $37.6 $15,308 - $32,336
860 Added 34.51%
3,352 $88,000
Q3 2019

Nov 07, 2019

BUY
$30.31 - $48.63 $75,532 - $121,185
2,492 New
2,492 $79,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $445M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.